Dafna Capital Management LLC Merus N.V. Transaction History

Dafna Capital Management LLC

$368 Million
Q4 2024

A detailed history of Dafna Capital Management LLC transactions in Merus N.V. stock. As of the latest transaction made, Dafna Capital Management LLC holds 451,804 shares of MRUS stock, worth $21.4 Million. This represents 5.16% of its overall portfolio holdings.

Number of Shares

451,804

Previous 412,573 9.51%

Holding current value

$21.4 Million

Previous $20.6 Million 7.83%

% of portfolio

5.16%

Previous 5.3%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$41.45 - $54.5 $1.63 Million - $2.14 Million	39,231 Added 9.51%	451,804 $19 Million
Q3 2024 Nov 14, 2024	BUY	$47.19 - $58.84 $147,610 - $184,051	3,128 Added 0.76%	412,573 $20.6 Million
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $1.21 Million - $1.83 Million	30,450 Added 8.03%	409,445 $24.2 Million
Q1 2024 May 15, 2024	SELL	$28.03 - $51.82 $2.13 Million - $3.93 Million	-75,875 Reduced 16.68%	378,995 $17.1 Million
Q4 2023 Feb 14, 2024	SELL	$20.06 - $28.66 $601,800 - $859,800	-30,000 Reduced 6.19%	454,870 $12.5 Million
Q3 2023 Nov 14, 2023	BUY	$20.13 - $27.29 $2.01 Million - $2.73 Million	100,000 Added 25.98%	484,870 $11.4 Million
Q2 2023 Aug 14, 2023	BUY	$18.33 - $27.18 $1.85 Million - $2.74 Million	100,872 Added 35.52%	384,870 $10.1 Million
Q1 2023 May 15, 2023	BUY	$14.25 - $20.5 $200,996 - $289,152	14,105 Added 5.23%	283,998 $5.23 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $89,600 - $165,620	-7,000 Reduced 2.53%	269,893 $4.18 Million
Q3 2022 Nov 14, 2022	BUY	$18.64 - $28.93 $260,997 - $405,077	14,002 Added 5.33%	276,893 $5.55 Million
Q2 2022 Aug 15, 2022	BUY	$13.98 - $29.25 $390,069 - $816,133	27,902 Added 11.87%	262,891 $5.95 Million
Q1 2022 May 16, 2022	BUY	$23.58 - $30.91 $209,861 - $275,099	8,900 Added 3.94%	234,989 $6.21 Million
Q4 2021 Feb 14, 2022	BUY	$20.0 - $32.29 $1.88 Million - $3.04 Million	94,140 Added 71.35%	226,089 $7.19 Million
Q3 2021 Nov 15, 2021	SELL	$16.48 - $27.23 $426,700 - $705,039	-25,892 Reduced 16.4%	131,949 $2.9 Million
Q1 2021 May 17, 2021	BUY	$16.14 - $29.11 $2.55 Million - $4.59 Million	157,841 New	157,841 $3.3 Million

Others Institutions Holding MRUS

# of Institutions

202

Shares Held

60.7M

Call Options Held

111K

Put Options Held

85.7K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.17B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Account

Dafna Capital Management LLC Merus N.V. Transaction History